China Pharma Holdings (CPHI) Operating Leases: 2019-2025
Historic Operating Leases for China Pharma Holdings (CPHI) over the last 5 years, with Sep 2025 value amounting to $198,583.
- China Pharma Holdings' Operating Leases was N/A to $198,583 in Q3 2025 from the same period last year, while for Sep 2025 it was $198,583, marking a year-over-year change of. This contributed to the annual value of $39,323 for FY2024, which is 1.47% down from last year.
- China Pharma Holdings' Operating Leases amounted to $198,583 in Q3 2025, which was up 405.00% from $39,323 recorded in Q4 2024.
- In the past 5 years, China Pharma Holdings' Operating Leases ranged from a high of $198,583 in Q3 2025 and a low of $20,008 during Q1 2024.
- Over the past 3 years, China Pharma Holdings' median Operating Leases value was $39,910 (recorded in 2023), while the average stood at $86,519.
- In the last 5 years, China Pharma Holdings' Operating Leases skyrocketed by 307.55% in 2022 and then crashed by 81.08% in 2023.
- Quarterly analysis of 5 years shows China Pharma Holdings' Operating Leases stood at $85,282 in 2021, then tumbled by 52.57% to $40,445 in 2022, then decreased by 1.32% to $39,910 in 2023, then decreased by 1.47% to $39,323 in 2024, then reached $198,583 in 2025.
- Its Operating Leases was $198,583 in Q3 2025, compared to $39,323 in Q4 2024 and $20,008 in Q1 2024.